JPS6353998B2 - - Google Patents
Info
- Publication number
- JPS6353998B2 JPS6353998B2 JP11834381A JP11834381A JPS6353998B2 JP S6353998 B2 JPS6353998 B2 JP S6353998B2 JP 11834381 A JP11834381 A JP 11834381A JP 11834381 A JP11834381 A JP 11834381A JP S6353998 B2 JPS6353998 B2 JP S6353998B2
- Authority
- JP
- Japan
- Prior art keywords
- ethynyl
- formula
- general formula
- acid
- produced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 150000004820 halides Chemical class 0.000 claims description 4
- 125000004423 acyloxy group Chemical group 0.000 claims description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 15
- 150000003431 steroids Chemical class 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000002994 raw material Substances 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 4
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- LUJVUUWNAPIQQI-QAGGRKNESA-N androsta-1,4-diene-3,17-dione Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 LUJVUUWNAPIQQI-QAGGRKNESA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- AUBCMGXPBMGRFT-UHFFFAOYSA-N octane;oxolane Chemical compound C1CCOC1.CCCCCCCC AUBCMGXPBMGRFT-UHFFFAOYSA-N 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- LUJVUUWNAPIQQI-UHFFFAOYSA-N (+)-androsta-1,4-diene-3,17-dione Natural products O=C1C=CC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 LUJVUUWNAPIQQI-UHFFFAOYSA-N 0.000 description 1
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- IATKKATWPOVYCC-VMXHOPILSA-N (8s,9s,10r,13s,14s)-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1CC2=CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CCC[C@@]1(C)CC2 IATKKATWPOVYCC-VMXHOPILSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- YLFRRPUBVUAHSR-RRPFGEQOSA-N 16,17-didehydropregnenolone Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC=C(C(=O)C)[C@@]1(C)CC2 YLFRRPUBVUAHSR-RRPFGEQOSA-N 0.000 description 1
- YLFRRPUBVUAHSR-UHFFFAOYSA-N 16-dehydro-pregnenolone Natural products C1C=C2CC(O)CCC2(C)C2C1C1CC=C(C(=O)C)C1(C)CC2 YLFRRPUBVUAHSR-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- -1 4.0 ml Chemical compound 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- SNMVJSSWZSJOGL-PLOWYNNNSA-N 9alpha-hydroxyandrost-4-en-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@@]3(O)CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 SNMVJSSWZSJOGL-PLOWYNNNSA-N 0.000 description 1
- HJTUINCBGMVXOB-LNMJFAINSA-N Androsta-4,9(11)-diene-3,17-dione Chemical compound O=C1CC[C@]2(C)C3=CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 HJTUINCBGMVXOB-LNMJFAINSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- UMYZHWLYICNGRQ-UHFFFAOYSA-N ethanol;heptane Chemical compound CCO.CCCCCCC UMYZHWLYICNGRQ-UHFFFAOYSA-N 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
Description
本発明はアシルオキシステロイド及びその製法
に関し、さらに詳しくはヒドロコルチゾン、プレ
ドニソロン等の副腎皮質ホルモン製造の新規な中
間体として有用な17β−エチニル−17α−アシル
オキシステロイドとその製法に関する。
最近、コレステロールあるいはシトステロール
等のステロール類よりミコバクテリウム属等の微
生物によつて大量かつ安価にアンドロスト−4−
エン−3,17−ジオン、アンドロスタ−1,4−
ジエン−3,17−ジオンが生産されるようにな
り、エストロン、テストステロン、スピロノラク
トン等の各種ステロイド医薬がこれら原料から生
産されるようになつた。
一方、ステロイド医薬の過半を占める副腎皮質
ホルモン(コルチコイド)は依然スチグマステロ
ールからのプロゲステロン、ジオスゲニンからの
16−デヒドロプレグネノロンを中間原料とする
か、あるいは胆汁酸を原料とする長い工程によつ
て製造されている。
本発明者らは、近年、大量かつ安価に供給され
るようになつた前述のアンドロスト−4−エン−
3,17−ジオン、アンドロスタ−1,4−ジエン
−3,17−ジオンのみならず、同じく近年醗酵生
産されるに至つた9α−ヒドロキシアンドロスト
−4−エン−3,17−ジオンから生産されるアン
ドロスタ−4,9(11)−ジエン−3,17−ジオンを
原料とし、より経済的なコルチコイド類の製造法
を開発すべく研究に着手した。
その結果、これら原料からコルチコイド製造に
極めて有利な一般式()で示される新規な17β
−エチニル−17α−アシルオキシステロイド類を
製造することができた。
(式中、点線は単結合か二重結合、Xはアシルオ
キシ基を表わす。)
以下、本発明について詳細に説明する。
一般式()で示される化合物とは、17β−エ
チニル−17α−ヒドロキシアンドロスト−4−エ
ン−3−オン、17β−エチニル−17α−ヒドロキ
シアンドロスタ−1,4−ジエン−3−オン、
17β−エチニル−17α−ヒドロキシアンドロスタ
−4,9(11)−ジエン−3−オン、17β−エチニル
−17α−ヒドロキシアンドロスト−1,4,9(11)
−トリエン−3−オン等と、たとえば酢酸、プロ
ピオン酸、安息香酸などカルボン酸類とのエステ
ル類であり、これらは下式に示す反応経路によつ
て容易にコルチコイドに誘導できる。
The present invention relates to an acyloxysteroid and a method for producing the same, and more particularly to a 17β-ethynyl-17α-acyloxysteroid useful as a new intermediate for producing adrenocortical hormones such as hydrocortisone and prednisolone, and a method for producing the same. Recently, androst-4-4 has been produced using microorganisms such as Mycobacterium in large quantities and at low cost, rather than sterols such as cholesterol or sitosterol.
ene-3,17-dione, androsta-1,4-
Diene-3,17-dione began to be produced, and various steroid drugs such as estrone, testosterone, and spironolactone began to be produced from these raw materials. On the other hand, adrenal corticosteroids (corticoids), which account for the majority of steroid medicines, are still derived from progesterone from stigmasterol and diosgenin.
It is produced by a long process using 16-dehydropregnenolone as an intermediate raw material or bile acids as raw material. The present inventors have discovered the above-mentioned androst-4-ene, which has recently become available in large quantities and at low cost.
Produced not only from 3,17-dione and androst-1,4-diene-3,17-dione, but also from 9α-hydroxyandrost-4-ene-3,17-dione, which has also recently been produced by fermentation. We have begun research to develop a more economical method for producing corticoids using androsta-4,9 (11) -diene-3,17-dione, which is produced by the present invention, as a raw material. As a result, we discovered a novel 17β, represented by the general formula (), which is extremely advantageous for producing corticoids from these raw materials.
-Ethynyl-17α-acyloxysteroids could be produced. (In the formula, the dotted line represents a single bond or a double bond, and X represents an acyloxy group.) The present invention will be explained in detail below. The compounds represented by the general formula () include 17β-ethynyl-17α-hydroxyandrost-4-en-3-one, 17β-ethynyl-17α-hydroxyandrost-1,4-dien-3-one,
17β-ethynyl-17α-hydroxyandrost-4,9 (11) -dien-3-one, 17β-ethynyl-17α-hydroxyandrost-1,4,9 (11)
These are esters of -trien-3-one etc. and carboxylic acids such as acetic acid, propionic acid and benzoic acid, and these can be easily converted into corticoids by the reaction route shown in the following formula.
【表】
一般式()で示される17β−エチニル−17α
−アシルオキシステロイドは、下記に示す反応経
路によつて製造される一般式()で示される
17β−エチニル−17α−ヒドロキシステロイド類
に、カルボン酸の酸無水物又は酸ハロゲン化物を
反応させて製造される。
(式中、点線は単結合か二重結合を表わす。)
その第1の方法は一般式()で示される17β
−エチニル−17α−ヒドロキシステロイドをピリ
ジンなどの芳香族アミン中で無水酢酸などカルボ
ン酸酸無水物を作用させて実施できる。この場
合、酸無水物はステロイドに対し等モル以上、好
ましくは5倍モル以上が必要である。反応温度は
80〜150℃、好ましくは100〜135℃である。
第2の方法は、一般式()で示されるステロ
イドを酢酸などのカルボン酸類を溶媒として、こ
れにカルボン酸酸無水物を作用させて実施でき
る。この場合、p−トルエンスルホン酸、トリフ
ルオロ酢酸、硫酸、リン酸、塩化亜鉛、塩化鉄、
など酸性化合物あるいはルイス酸類が触媒として
使用される。反応温度は通常0〜50℃である。
第3の方法は、一般式()で示されるステロ
イドをベンゼン、トルエン、四塩化炭素、ジクロ
ルエタンなどの通常よく使用される溶媒中で、無
水酢酸などのカルボン酸酸無水物をジメチルアミ
ノピリジンなどのピリジン類を触媒として実施で
きる。触媒のジメチルアミノピリジン類はステロ
イド類に対し1〜50モル%であり、好ましくは5
〜10モル%である。酸無水物は、ステロイドの等
モル以上、好ましくは5倍モル以上必要である。
反応温度は5〜150℃、好ましくは20〜100℃であ
る。この場合、トリエチルアミン、トリメチルア
ミン、ベンジルアミンなど、触媒として使用され
たジメチルアミノピリジンなどのピリジン類より
も塩基性の強い塩基性物質を添加し、生成するカ
ルボン酸類を中和する必要がある。
第4の方法は、一般式()で示されるステロ
イドをピリジンなどの塩基性溶媒中で塩化アセチ
ルなどのカルボン酸の酸ハロゲン化物を作用させ
て実施例できる。酸ハロゲン化物はステロイドに
対し1〜10倍モル必要である。反応温度は0〜
150℃、好ましくは30〜100℃である。
以下に実施例を挙げて本発明を更に詳細に説明
する。
実施例 1
17β−エチニル−17α−ヒドロキシアンドロス
タ−1,4−ジエン−3−オン12.0gにピリジン
50ml、無水酢酸50mlを加え120℃で30時間加熱す
る。反応物を氷水中に注ぎ分離したタール状物質
をジクロルメタンで抽出する。有機層を5%塩酸
水溶液、次いで5%炭酸水素ナトリウム水溶液で
洗滌する。分離された有機層は無水硫酸ナトリウ
ムで乾燥したのち濃縮する。濃縮物はアルミナ
250gを充填したカラムに仕込み、ベンゼン−酢
酸エチル(9:1)混合溶媒500mlで流出させる。
12.3gの結晶が得られる。オクタン−テトラヒド
ロフラン(20:1)、ヘプタン−エタノール
(5:1)、オクタン−テトラヒドロフラン(30:
7)より再結晶すると、17β−エチル−17α−ア
セトキシアンドロスタ−1,4−ジエン−3−オ
ン8.1gが得られる。融点171.8〜172.6℃(昇温速
度1℃/min)
NMRスペクトル(CDCl3)
δppm 1.00(S、3H)、1.26(S、3H)、2.02(S、
3H)、2.56(S、1H)、6.04(S、1H)、6.15(q、
1H)、6.98(d、1H)
実施例 2
17β−エチニル−17α−ヒドロキシアンドロス
タ−1,4−ジエン−3−オン2.0gに無水酢酸
2.0ml、トリエチルアミン2.0ml、ジメチルアミノ
ピリジン0.114g、トルエン5.0mlを加え80〜90℃
で11時間加熱する。冷却後、実施例1の操作に従
つて生成物をジクロルメタンで抽出する。抽出物
を液体クロマトグラフイーで分析する。96.7モル
%の収率で17β−エチル−17α−アセトキシアン
ドロスタ−1,4−ジエン−3−オンが得られ
る。
実施例 3
17β−エチニル−17α−ヒドロキシアンドロス
タ−1,4−ジエン−3−オン2.0gに酢酸10.0
ml、無水酢酸4.0ml、塩化亜鉛0.4gを加え、室温
で25時間撹拌する。実施例1と同様の方法で生成
物をジクロルメタンで抽出する。抽出物を液体ク
ロマトグラフイーで分析する。17β−エチニル−
17α−アセトキシアンドロスタ−1,4−ジエン
−3−オンが77.2モル%で得られる。[Table] 17β-ethynyl-17α represented by general formula ()
-Acyloxysteroids are produced by the reaction route shown below and are represented by the general formula ().
It is produced by reacting 17β-ethynyl-17α-hydroxysteroids with carboxylic acid anhydrides or acid halides. (In the formula, the dotted line represents a single bond or a double bond.) The first method is 17β shown in the general formula ().
-Ethynyl-17α-hydroxysteroid can be reacted with a carboxylic acid anhydride such as acetic anhydride in an aromatic amine such as pyridine. In this case, the acid anhydride should be used in an amount equal to or more than 5 times the molar amount of the steroid, preferably 5 times or more. The reaction temperature is
The temperature is 80-150°C, preferably 100-135°C. The second method can be carried out by using a carboxylic acid such as acetic acid as a solvent and allowing a carboxylic acid anhydride to act on the steroid represented by the general formula (). In this case, p-toluenesulfonic acid, trifluoroacetic acid, sulfuric acid, phosphoric acid, zinc chloride, iron chloride,
Acidic compounds such as Lewis acids or Lewis acids are used as catalysts. The reaction temperature is usually 0 to 50°C. The third method involves adding a steroid represented by the general formula () to a commonly used solvent such as benzene, toluene, carbon tetrachloride, dichloroethane, etc., and adding a carboxylic acid anhydride such as acetic anhydride to dimethylaminopyridine or the like. This can be carried out using pyridines as a catalyst. The amount of dimethylaminopyridine used as a catalyst is 1 to 50% by mole based on the steroid, preferably 5% by mole based on the steroid.
~10 mol%. The acid anhydride is required in an amount equal to or more than the same molar amount as the steroid, preferably at least 5 times the molar amount.
The reaction temperature is 5-150°C, preferably 20-100°C. In this case, it is necessary to neutralize the produced carboxylic acids by adding a basic substance such as triethylamine, trimethylamine, or benzylamine that is more basic than the pyridine such as dimethylaminopyridine used as a catalyst. The fourth method can be carried out by reacting a steroid represented by the general formula () with an acid halide of a carboxylic acid such as acetyl chloride in a basic solvent such as pyridine. The acid halide is required in a molar amount 1 to 10 times that of the steroid. The reaction temperature is 0~
The temperature is 150°C, preferably 30-100°C. The present invention will be explained in more detail with reference to Examples below. Example 1 12.0 g of 17β-ethynyl-17α-hydroxyandrosta-1,4-dien-3-one and pyridine
Add 50 ml and 50 ml of acetic anhydride and heat at 120°C for 30 hours. The reaction mixture was poured into ice water and the separated tar-like substance was extracted with dichloromethane. The organic layer is washed with a 5% aqueous hydrochloric acid solution and then with a 5% aqueous sodium bicarbonate solution. The separated organic layer is dried over anhydrous sodium sulfate and then concentrated. Concentrate is alumina
A column packed with 250 g of the solution was charged and eluted with 500 ml of a benzene-ethyl acetate (9:1) mixed solvent.
12.3 g of crystals are obtained. Octane-tetrahydrofuran (20:1), heptane-ethanol (5:1), octane-tetrahydrofuran (30:
Recrystallization from 7) yields 8.1 g of 17β-ethyl-17α-acetoxyandrosta-1,4-dien-3-one. Melting point 171.8-172.6℃ (heating rate 1℃/min) NMR spectrum (CDCl 3 ) δppm 1.00 (S, 3H), 1.26 (S, 3H), 2.02 (S,
3H), 2.56 (S, 1H), 6.04 (S, 1H), 6.15 (q,
1H), 6.98 (d, 1H) Example 2 2.0 g of 17β-ethynyl-17α-hydroxyandrosta-1,4-dien-3-one and acetic anhydride
Add 2.0ml, triethylamine 2.0ml, dimethylaminopyridine 0.114g, and toluene 5.0ml to 80-90℃.
Heat for 11 hours. After cooling, the product is extracted with dichloromethane according to the procedure of Example 1. The extract is analyzed by liquid chromatography. 17β-ethyl-17α-acetoxyandrosta-1,4-dien-3-one is obtained with a yield of 96.7 mol%. Example 3 10.0 g of acetic acid in 2.0 g of 17β-ethynyl-17α-hydroxyandrosta-1,4-dien-3-one
ml, acetic anhydride, 4.0 ml, and zinc chloride, 0.4 g, and stirred at room temperature for 25 hours. The product is extracted with dichloromethane in a similar manner to Example 1. The extract is analyzed by liquid chromatography. 17β-ethynyl-
77.2 mol % of 17α-acetoxyandrosta-1,4-dien-3-one is obtained.
Claims (1)
アシルオキシ基を表わす。) で示される17β−エチニル−17α−アシルオキシ
ステロイド。 2 一般式() (式中、点線は単結合か二重結合を表わす。) で示される17β−エチニル−17α−ヒドロキシス
テロイドにカルボン酸の酸無水物又は酸ハロゲン
化物を反応させ、 一般式() (式中、点線は単結合か二重結合を表わし、Xは
アシルオキシ基を表わす。) で示される17β−エチニル−17α−アシルオキシ
ステロイドを製造することを特徴とするアシルオ
キシステロイドの製法。[Claims] 1 General formula () (In the formula, the dotted line represents a single bond or a double bond, and X represents an acyloxy group.) A 17β-ethynyl-17α-acyloxysteroid. 2 General formula () (In the formula, the dotted line represents a single bond or a double bond.) A 17β-ethynyl-17α-hydroxysteroid represented by the formula is reacted with a carboxylic acid anhydride or an acid halide to obtain the general formula (). (In the formula, the dotted line represents a single bond or a double bond, and X represents an acyloxy group.)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11834381A JPS5821698A (en) | 1981-07-28 | 1981-07-28 | Acyloxysteroid and its preparation |
US06/325,026 US4585591A (en) | 1980-12-10 | 1981-11-25 | 17β-ethynylsteroids and process for preparing same |
HU813691A HU187382B (en) | 1980-12-10 | 1981-12-08 | Process for producing 17-beta-ethnyl-steroides |
EP81110321A EP0053845B1 (en) | 1980-12-10 | 1981-12-10 | 17-beta-ethynylsteroids and process for preparing same |
DE8181110321T DE3169906D1 (en) | 1980-12-10 | 1981-12-10 | 17-beta-ethynylsteroids and process for preparing same |
AT81110321T ATE12648T1 (en) | 1980-12-10 | 1981-12-10 | 17-BETA-AETHYNYL STEROIDS AND PROCESS FOR THEIR PREPARATION. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11834381A JPS5821698A (en) | 1981-07-28 | 1981-07-28 | Acyloxysteroid and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5821698A JPS5821698A (en) | 1983-02-08 |
JPS6353998B2 true JPS6353998B2 (en) | 1988-10-26 |
Family
ID=14734329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11834381A Granted JPS5821698A (en) | 1980-12-10 | 1981-07-28 | Acyloxysteroid and its preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5821698A (en) |
-
1981
- 1981-07-28 JP JP11834381A patent/JPS5821698A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5821698A (en) | 1983-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5618807A (en) | Method for preparing 17-substituted steroids useful in cancer treatment | |
JP3977462B2 (en) | 11- (Substituted phenyl) -estradi-4,9-diene derivatives | |
JPS6228158B2 (en) | ||
US5194602A (en) | 9α-hydroxy-17-methylene steroids, process for their preparation and their use in the preparation of corticosteroids | |
JP2009518377A (en) | High purity 17α-cyanomethyl-17β-hydroxy-estradi-4,9-dien-3-one and method for synthesizing the same | |
US5585482A (en) | Preparation of 11-keto steroids | |
JPS6340198B2 (en) | ||
Carruthers et al. | Synthesis of corticoids from 9. alpha.-hydroxyandrost-4-ene-3, 17-dione | |
US6768014B2 (en) | PROCESS FOR PREPARING 17α-ACETOXY-11β-[4-N,N(DIMETHYLAMINO)PHENYL]-21-METHOXY-19-NORPREGNA-4,9-DIENE-3,20-DIONE, INTERMEDIATES USEFUL IN THE PROCESS , AND PROCESSES FOR PREPARING SUCH INTERMEDIATES | |
CA1085820A (en) | Method for the preparation of esters | |
JPS6356235B2 (en) | ||
JPH0475919B2 (en) | ||
EP0153001B1 (en) | Steroids having an enamide or enimide group and their preparation | |
JPH0276896A (en) | Steroid compound and production thereof | |
EP0256095A1 (en) | Anti-inflammatory carboxy pregnane derivatives. | |
JPS6353998B2 (en) | ||
US4585590A (en) | Cyanohydrin process | |
JPS636559B2 (en) | ||
US4585591A (en) | 17β-ethynylsteroids and process for preparing same | |
US5241063A (en) | Process for the preparation of steroids bearing 17α-hydroxy-20-oxopregnane side chain | |
US4440689A (en) | Acyloxysteroids and process for producing same | |
JPS6362516B2 (en) | ||
US4370271A (en) | Process for the partial reduction of C21-steroid carboxylic acids and their esters to C21-steroid alcohols and new C21-steroid alcohols | |
JPS6353995B2 (en) | ||
US4446072A (en) | Process for degrading the 20-carboxyl group of Δ4-Steroid-20-carboxylic acids |